REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206,689 | -54.7% | 18,020 | 0.0% | 0.01% | -38.9% |
| Q2 2023 | $456,086 | -21.4% | 18,020 | 0.0% | 0.02% | -30.8% |
| Q1 2023 | $580,424 | +74.5% | 18,020 | 0.0% | 0.03% | +73.3% |
| Q4 2022 | $332,649 | -59.3% | 18,020 | -40.4% | 0.02% | -59.5% |
| Q3 2022 | $817,000 | +95.5% | 30,256 | 0.0% | 0.04% | +131.2% |
| Q2 2022 | $418,000 | -27.7% | 30,256 | +2.0% | 0.02% | -30.4% |
| Q1 2022 | $578,000 | +19.4% | 29,657 | 0.0% | 0.02% | +15.0% |
| Q4 2021 | $484,000 | -40.7% | 29,657 | +1.3% | 0.02% | -51.2% |
| Q3 2021 | $816,000 | -6.0% | 29,274 | 0.0% | 0.04% | -6.8% |
| Q2 2021 | $868,000 | +6.1% | 29,274 | 0.0% | 0.04% | 0.0% |
| Q1 2021 | $818,000 | -99.9% | 29,274 | 0.0% | 0.04% | -8.3% |
| Q4 2020 | $829,625,000 | – | 29,274 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |